- Home
- Publications
- Publication Search
- Publication Details
Title
FMRP modulates the Wnt signalling pathway in glioblastoma
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 13, Issue 8, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-18
DOI
10.1038/s41419-022-05019-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The molecular biology of FMRP: new insights into fragile X syndrome
- (2021) Joel D. Richter et al. NATURE REVIEWS NEUROSCIENCE
- Diffuse Glioma Heterogeneity and Its Therapeutic Implications
- (2021) James G. Nicholson et al. Cancer Discovery
- Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma
- (2021) Karina Biserova et al. Cells
- The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy
- (2021) Vincenzo Mattei et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- FMR1/circCHAF1A/miR-211-5p/HOXC8 feedback loop regulates proliferation and tumorigenesis via MDM2-dependent p53 signaling in GSCs
- (2021) Yang Jiang et al. ONCOGENE
- Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge
- (2021) Simone Carotti et al. ONCOGENE
- WNT5B in Physiology and Disease
- (2021) Sarocha Suthon et al. Frontiers in Cell and Developmental Biology
- Post-translational Control of RNA-Binding Proteins and Disease-Related Dysregulation
- (2021) Alejandro Velázquez-Cruz et al. Frontiers in Molecular Biosciences
- FMRP regulates STAT3 mRNA localization to cellular protrusions and local translation to promote hepatocellular carcinoma metastasis
- (2021) Zhifa Shen et al. Communications Biology
- FMRP Control of Ribosome Translocation Promotes Chromatin Modifications and Alternative Splicing of Neuronal Genes Linked to Autism
- (2020) Sneha Shah et al. Cell Reports
- RNA-binding proteins in tumor progression
- (2020) Hai Qin et al. Journal of Hematology & Oncology
- BET degrader inhibits tumor progression and stem-like cell growth via Wnt/β-catenin signaling repression in glioma cells
- (2020) Tao Tian et al. Cell Death & Disease
- The Fragile X Mental Retardation Protein regulates RIP1K and colorectal cancer resistance to necroptosis
- (2020) Antonio Di Grazia et al. Cellular and Molecular Gastroenterology and Hepatology
- The involvement of noncanonical Wnt signaling in cancers
- (2020) Yongfeng Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- NMDA Receptor Signaling Mediates cFos Expression via Top2β-Induced DSBs in Glioblastoma Cells
- (2019) Henrik Lutz et al. Cancers
- A Synaptic Perspective of Fragile X Syndrome and Autism Spectrum Disorders
- (2019) Claudia Bagni et al. NEURON
- Transcriptomic metaanalyses of autistic brains reveals shared gene expression and biological pathway abnormalities with cancer
- (2019) Jaume Forés-Martos et al. Molecular Autism
- Electrical and synaptic integration of glioma into neural circuits
- (2019) Humsa S. Venkatesh et al. NATURE
- Glioblastoma invasion and NMDA receptors: A novel prospect
- (2019) DN Nandakumar et al. Physiology International
- Patient-Derived Glioma Models: From Patients to Dish to Animals
- (2019) Cintia Carla da Hora et al. Cells
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
- (2019) Quinn T Ostrom et al. NEURO-ONCOLOGY
- FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory
- (2019) Kirsty Sawicka et al. eLife
- ETS-1 Expression Is Hypoxia-independent in Glioblastoma-derived Endothelial and Mesenchymal Stem-like Cells
- (2018) DOMINIK KOESSINGER et al. ANTICANCER RESEARCH
- Aberrant RNA translation in fragile X syndrome: From FMRP mechanisms to emerging therapeutic strategies
- (2018) Anwesha Banerjee et al. BRAIN RESEARCH
- GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth
- (2018) Leanne Li et al. CANCER CELL
- Relapse pathway of glioblastoma revealed by single-cell molecular analysis
- (2018) Xuelian Chen et al. CARCINOGENESIS
- Cell line-based xenograft mouse model of paediatric glioma stem cells mirrors the clinical course of the patient
- (2018) Susanna Larsson et al. CARCINOGENESIS
- HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein
- (2018) Thomas Maurin et al. NUCLEIC ACIDS RESEARCH
- Cellular and molecular mechanisms of glioblastoma malignancy: implications in resistance and therapeutic strategies
- (2018) Joana Balça-Silva et al. SEMINARS IN CANCER BIOLOGY
- Widespread RNA editing dysregulation in brains from autistic individuals
- (2018) Stephen S. Tran et al. NATURE NEUROSCIENCE
- The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response
- (2017) Quintino Giorgio D’Alessandris et al. NEURO-ONCOLOGY
- A novel role of fragile X mental retardation protein in pre-mRNA alternative splicing through RNA-binding protein 14
- (2017) Lin-Tao Zhou et al. NEUROSCIENCE
- Absence of the Fragile X Mental Retardation Protein results in defects of RNA editing of neuronal mRNAs in mouse
- (2017) Alice Filippini et al. RNA Biology
- The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells
- (2017) Francesca Zalfa et al. Cell Death & Disease
- Fragile X syndrome
- (2017) Randi J. Hagerman et al. Nature Reviews Disease Primers
- Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells
- (2016) Elena Binda et al. CANCER RESEARCH
- Dynamic mRNA Transport and Local Translation in Radial Glial Progenitors of the Developing Brain
- (2016) Louis-Jan Pilaz et al. CURRENT BIOLOGY
- Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells
- (2016) Yingge Wang et al. Molecular Medicine Reports
- MDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrome
- (2016) Yue Li et al. Science Translational Medicine
- Autism and Cancer Share Risk Genes, Pathways, and Drug Targets
- (2016) Jacqueline N. Crawley et al. TRENDS IN GENETICS
- Fragile X mental retardation protein promotes astrocytoma proliferation via the MEK/ERK signaling pathway
- (2016) Zhou Xing et al. Oncotarget
- Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy
- (2016) Yang Yi et al. Frontiers in Pharmacology
- RNA-binding proteins, multifaceted translational regulators in cancer
- (2015) Laurence Wurth et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Dysregulation and restoration of translational homeostasis in fragile X syndrome
- (2015) Joel D. Richter et al. NATURE REVIEWS NEUROSCIENCE
- Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome
- (2015) Emanuela Pasciuto et al. NEURON
- The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders
- (2015) Sien Braat et al. NEURON
- Fmrp Interacts with Adar and Regulates RNA Editing, Synaptic Density and Locomotor Activity in Zebrafish
- (2015) Adi Shamay-Ramot et al. PLoS Genetics
- Epidemiologic and Molecular Prognostic Review of Glioblastoma
- (2014) J. P. Thakkar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- SnapShot: FMRP mRNA Targets and Diseases
- (2014) Emanuela Pasciuto et al. CELL
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- Dissecting the expression landscape of RNA-binding proteins in human cancers
- (2014) Bobak Kechavarzi et al. GENOME BIOLOGY
- Hijacking the Neuronal NMDAR Signaling Circuit to Promote Tumor Growth and Invasion
- (2013) Leanne Li et al. CELL
- The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation
- (2013) Rossella Lucá et al. EMBO Molecular Medicine
- The translation of translational control by FMRP: therapeutic targets for FXS
- (2013) Jennifer C Darnell et al. NATURE NEUROSCIENCE
- RNA-binding proteins in Mendelian disease
- (2013) Alfredo Castello et al. TRENDS IN GENETICS
- Patient-Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas In Situ
- (2013) Kyeung Min Joo et al. Cell Reports
- Epigenetic silencing ofId4identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis
- (2012) Maurizio Martini et al. CANCER
- Mutations causing syndromic autism define an axis of synaptic pathophysiology
- (2011) Benjamin D. Auerbach et al. NATURE
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Altered mRNA transport, docking, and protein translation in neurons lacking fragile X mental retardation protein
- (2010) D.-I. Kao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Fragile X Syndrome Protein Represses Activity-Dependent Translation through CYFIP1, a New 4E-BP
- (2008) Ilaria Napoli et al. CELL
- Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme
- (2008) R. Pallini et al. CLINICAL CANCER RESEARCH
- A Direct Role for FMRP in Activity-Dependent Dendritic mRNA Transport Links Filopodial-Spine Morphogenesis to Fragile X Syndrome
- (2008) Jason B. Dictenberg et al. DEVELOPMENTAL CELL
- Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme
- (2008) Maurizio Martini et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started